Browse Category

Industry Leaders News 22 June 2025 - 1 October 2025

NVIDIA’s $4 Trillion AI Revolution: How the Chipmaker Overtook Apple and Microsoft

AI’s “iPhone Moment” Arrives — Nvidia CEO Jensen Huang Explains What It Means

What Is the “iPhone Moment” of AI? Huang’s “iPhone moment” analogy captures the idea that generative AI (like ChatGPT) has suddenly become a consumer and enterprise phenomenon. Just as the iPhone in 2007 turned smartphones into a mass-market platform (spurting new apps, services and industries), ChatGPT and related AI tools in 2022-2023 have made AI easy and compelling for ordinary users. “Startups are racing to build disruptive products and business models,” Huang said at Nvidia’s 2023 GTC conference, “and incumbents are looking to respond.” nvidianews.nvidia.com. The implication: we’re entering a phase where AI moves out of niche labs and into
AI Titans Clash: OpenAI vs Anthropic vs Google DeepMind – Who Will Dominate the Future of AI?

AI Titans Clash: OpenAI vs Anthropic vs Google DeepMind – Who Will Dominate the Future of AI?

OpenAI was founded in 2015 by Elon Musk, Sam Altman and others, restructured in 2019 into a capped-profit model, and by late 2024 was valued at about $150 billion after ChatGPT’s rapid adoption. GPT-4, released in March 2023, is OpenAI’s multimodal model that accepts text and images, with a context window up to 32K tokens and top performance on benchmarks such as the Bar Exam. Anthropic, founded in 2021 by Dario and Daniela Amodei, emphasizes safety with Constitutional AI and released Claude 2 in July 2023 featuring a 100,000-token context, with Claude 4 announced in May 2025 adding web browsing
Top 100 Global Biotechnology Companies Revolutionizing Science and Health

Top 100 Global Biotechnology Companies Revolutionizing Science and Health

Pfizer Inc., in collaboration with BioNTech, co-developed the first FDA-approved mRNA COVID-19 vaccine, Comirnaty. Roche Holding AG is the world’s largest biotech company and a leader in oncology treatments (Herceptin) and diagnostics. Moderna, Inc. pioneered mRNA vaccine technology and its COVID-19 vaccine was among the first mRNA medicines approved, while expanding mRNA therapeutics for cancer and rare diseases. Illumina, Inc. is a market leader in DNA sequencing with platforms such as NovaSeq that enabled the concept of a $1,000 genome. CRISPR Therapeutics AG is a leading CRISPR-Cas9 gene editing company developing exa-cel for sickle cell disease and other therapies. Ginkgo
Go toTop